<DOC>
	<DOCNO>NCT00809926</DOCNO>
	<brief_summary>To evaluate efficacy safety valsartan/aliskiren combination compare valsartan alone patient Stage 2 hypertension .</brief_summary>
	<brief_title>8 Weeks Study Evaluate Efficacy Safety Valsartan Combination With Aliskiren Compared Valsartan Alone Patients With Stage 2 Hypertension</brief_title>
	<detailed_description />
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Valsartan</mesh_term>
	<criteria>Patients eligible able participate study , give write informed consent assessment perform . Men woman 18 year old . Patients Stage 2 systolic hypertension ; define MSSBP ≥160 mmHg &lt; 180 mmHg Visit 5 ( randomization ) . Use aliskiren participation clinical trial aliskiren treatment within 30 day Visit 1 . Pregnant nursing ( lactate ) woman , pregnancy define state female conception termination gestation , confirm positive hCG laboratory test ( &gt; 5 mIU/ml ) . Women childbearing potential ( WOCBP ) , define woman physiologically capable become pregnant , include woman whose career , lifestyle , sexual orientation precludes intercourse male partner woman whose partner sterilize vasectomy mean , UNLESS meet follow definition postmenopausal : 12 month natural ( spontaneous ) amenorrhea 6 month spontaneous amenorrhea serum FSH level &gt; 40 mIU/m 6 week post surgical bilateral oophorectomy without hysterectomy OR use one follow acceptable method contraception : surgical sterilization ( e.g. , bilateral tubal ligation ) , hormonal contraception ( implantable , patch , oral ) , doublebarrier method . Reliable contraception maintain throughout study 7 day study drug discontinuation . Severe hypertension ( office cuff MSDBP ≥110 mmHg and/or MSSBP ≥180 mmHg ) . Refractory hypertension , define unresponsive triple drug therapy maximum dose drug , one must diuretic , blood pressure goal ( 140/90 mmHg ) . Patients treat 3 antihypertensive medication ( component combination drug count individually ) . History evidence secondary form hypertension .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2011</verification_date>
	<keyword>Hypertension , aliskiren valsartan</keyword>
</DOC>